Literature DB >> 18614517

Antipsychotics for people with dementia.

John O'Brien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18614517      PMCID： PMC2453249          DOI： 10.1136/bmj.a602

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Global prevalence of dementia: a Delphi consensus study.

Authors:  Cleusa P Ferri; Martin Prince; Carol Brayne; Henry Brodaty; Laura Fratiglioni; Mary Ganguli; Kathleen Hall; Kazuo Hasegawa; Hugh Hendrie; Yueqin Huang; Anthony Jorm; Colin Mathers; Paulo R Menezes; Elizabeth Rimmer; Marcia Scazufca
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

2.  Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

Authors:  Lon S Schneider; Karen Dagerman; Philip S Insel
Journal:  Am J Geriatr Psychiatry       Date:  2006-03       Impact factor: 4.105

3.  Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study.

Authors:  Sudeep S Gill; Paula A Rochon; Nathan Herrmann; Philip E Lee; Kathy Sykora; Nadia Gunraj; Sharon-Lise T Normand; Jerry H Gurwitz; Connie Marras; Walter P Wodchis; Muhammad Mamdani
Journal:  BMJ       Date:  2005-01-24

Review 4.  Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review.

Authors:  Liat Ayalon; Amber M Gum; Leilani Feliciano; Patricia A Areán
Journal:  Arch Intern Med       Date:  2006-11-13

5.  Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies.

Authors:  S Gauthier; Y Wirth; H J Möbius
Journal:  Int J Geriatr Psychiatry       Date:  2005-05       Impact factor: 3.485

6.  Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

Authors:  Lon S Schneider; Karen S Dagerman; Philip Insel
Journal:  JAMA       Date:  2005-10-19       Impact factor: 56.272

7.  The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.

Authors:  Ira Katz; Peter-Paul de Deyn; Jacobo Mintzer; Andrew Greenspan; Young Zhu; Henry Brodaty
Journal:  Int J Geriatr Psychiatry       Date:  2007-05       Impact factor: 3.485

8.  Donepezil for the treatment of agitation in Alzheimer's disease.

Authors:  Robert J Howard; Edmund Juszczak; Clive G Ballard; Peter Bentham; Richard G Brown; Roger Bullock; Alistair S Burns; Clive Holmes; Robin Jacoby; Tony Johnson; Martin Knapp; James Lindesay; John T O'Brien; Gordon Wilcock; Cornelius Katona; Roy W Jones; Julia DeCesare; Michaela Rodger
Journal:  N Engl J Med       Date:  2007-10-04       Impact factor: 91.245

9.  Antipsychotic drug use and mortality in older adults with dementia.

Authors:  Sudeep S Gill; Susan E Bronskill; Sharon-Lise T Normand; Geoffrey M Anderson; Kathy Sykora; Kelvin Lam; Chaim M Bell; Philip E Lee; Hadas D Fischer; Nathan Herrmann; Jerry H Gurwitz; Paula A Rochon
Journal:  Ann Intern Med       Date:  2007-06-05       Impact factor: 25.391

10.  A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial).

Authors:  Clive Ballard; Marisa Margallo Lana; Megan Theodoulou; Simon Douglas; Rupert McShane; Robin Jacoby; Katja Kossakowski; Ly-Mee Yu; Edmund Juszczak
Journal:  PLoS Med       Date:  2008-04-01       Impact factor: 11.069
View more
  6 in total

1.  Antipsychotics for dementia is metaphor for elderly care.

Authors:  Paddy Quail
Journal:  BMJ       Date:  2008-07-15

Review 2.  Withholding, discontinuing and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying?

Authors:  Carole Parsons; Carmel M Hughes; A Peter Passmore; Kate L Lapane
Journal:  Drugs Aging       Date:  2010-06-01       Impact factor: 3.923

3.  Patterns and trends in antipsychotic prescribing for Parkinson disease psychosis.

Authors:  Daniel Weintraub; Peijun Chen; Rosalinda V Ignacio; Eugenia Mamikonyan; Helen C Kales
Journal:  Arch Neurol       Date:  2011-07

4.  Psychotropic medication use among elderly nursing home residents in Slovenia: cross-sectional study.

Authors:  Marija Petek Šter; Eva Cedilnik Gorup
Journal:  Croat Med J       Date:  2011-02       Impact factor: 1.351

5.  Detection of mild cognitive impairment in people older than 65 years of age and its relationship to cardiovascular risk factors (DECRIVAM).

Authors:  M Victoria Perea-Bartolome; Ricardo García-García; Valentina Ladera-Fernández; Sara Mora-Simón; María C Patino-Alonso; Tita J Almanza-Guerra; Cristina Agudo-Conde; M Paz Muriel-Diez; Emiliano Rodríguez-Sánchez
Journal:  BMC Public Health       Date:  2011-06-27       Impact factor: 3.295

6.  Physical activity program for patients with dementia and their relative caregivers: randomized clinical trial in Primary Health Care (AFISDEMyF study).

Authors:  Emiliano Rodriguez-Sánchez; José María Criado-Gutiérrez; Sara Mora-Simón; M Paz Muriel-Diaz; Manuel A Gómez-Marcos; José I Recio-Rodríguez; M Carmen Patino-Alonso; Luis F Valero-Juan; José A Maderuelo-Fernandez; Luis García-Ortiz
Journal:  BMC Neurol       Date:  2014-04-01       Impact factor: 2.474
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.